BRIEF-Boehringer Ingelheim, Cue Biopharma Partner To Develop Autoimmune And Inflammatory Disease Treatments

Reuters
15 Apr
BRIEF-Boehringer Ingelheim, Cue Biopharma Partner To Develop Autoimmune And Inflammatory Disease Treatments

April 14 (Reuters) - Cue Biopharma Inc CUE.O:

  • BOEHRINGER INGELHEIM AND CUE BIOPHARMA PARTNER TO DEVELOP TREATMENT FOR AUTOIMMUNE AND INFLAMMATORY DISEASES

  • CUE BIOPHARMA INC: UNDER COLLABORATION, CO TO RECEIVE UP-FRONT PAYMENT OF $12 MILLION AS WELL AS RESEARCH SUPPORT PAYMENTS

  • CUE BIOPHARMA INC: CO IS ALSO ELIGIBLE TO EARN UP TO ABOUT $345 MILLION IN MILESTONE-BASED PAYMENTS

Source text: ID:nGNX8hQfzZ

Further company coverage: CUE.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10